Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA

Authors: Dodick et al.

Lancet. 2023 Nov 15:S0140-6736(23)01683-5. Online ahead of print.

PMID: 37979595 | DOI: 10.1016/S0140-6736(23)01683-5

Sign Up For An MSC Newsletter

Register to Watch the MSC Emerging Science Contest!

The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.



  • Content Types

  • Paper Categories

  • Paper Dates

Paper Categories

By Date